vs
Side-by-side financial comparison of AdvanSix Inc. (ASIX) and CRA INTERNATIONAL, INC. (CRAI). Click either name above to swap in a different company.
AdvanSix Inc. is the larger business by last-quarter revenue ($359.9M vs $197.0M, roughly 1.8× CRA INTERNATIONAL, INC.). CRA INTERNATIONAL, INC. runs the higher net margin — 6.7% vs -0.8%, a 7.5% gap on every dollar of revenue. On growth, CRA INTERNATIONAL, INC. posted the faster year-over-year revenue change (11.6% vs 9.4%). Over the past eight quarters, CRA INTERNATIONAL, INC.'s revenue compounded faster (7.1% CAGR vs 3.4%).
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
CRA INTERNATIONAL, INC.CRAIEarnings & Financial Report
CRA International, Inc. is a global consulting firm headquartered in Boston. The firm provides expert testimony and litigation support, strategic advice, and analysis to law firms, corporations, accounting firms, and governments.
ASIX vs CRAI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $359.9M | $197.0M |
| Net Profit | $-2.8M | $13.2M |
| Gross Margin | 7.6% | — |
| Operating Margin | -0.7% | 10.5% |
| Net Margin | -0.8% | 6.7% |
| Revenue YoY | 9.4% | 11.6% |
| Net Profit YoY | -892.9% | -12.0% |
| EPS (diluted) | $-0.11 | $1.99 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $359.9M | $197.0M | ||
| Q3 25 | $374.5M | $185.9M | ||
| Q2 25 | $410.0M | $186.9M | ||
| Q1 25 | $377.8M | $181.9M | ||
| Q4 24 | $329.1M | $176.4M | ||
| Q3 24 | $398.2M | $167.7M | ||
| Q2 24 | $453.5M | $171.4M | ||
| Q1 24 | $336.8M | $171.8M |
| Q4 25 | $-2.8M | $13.2M | ||
| Q3 25 | $-2.6M | $11.5M | ||
| Q2 25 | $31.4M | $12.1M | ||
| Q1 25 | $23.3M | $18.0M | ||
| Q4 24 | $352.0K | $15.0M | ||
| Q3 24 | $22.3M | $11.4M | ||
| Q2 24 | $38.9M | $6.5M | ||
| Q1 24 | $-17.4M | $13.7M |
| Q4 25 | 7.6% | — | ||
| Q3 25 | 6.8% | — | ||
| Q2 25 | 14.3% | — | ||
| Q1 25 | 14.2% | — | ||
| Q4 24 | 3.4% | — | ||
| Q3 24 | 14.4% | — | ||
| Q2 24 | 17.9% | — | ||
| Q1 24 | 0.9% | — |
| Q4 25 | -0.7% | 10.5% | ||
| Q3 25 | -0.9% | 9.3% | ||
| Q2 25 | 7.7% | 10.6% | ||
| Q1 25 | 7.7% | 14.0% | ||
| Q4 24 | -3.9% | 12.2% | ||
| Q3 24 | 7.5% | 11.0% | ||
| Q2 24 | 11.5% | 6.6% | ||
| Q1 24 | -7.0% | 11.4% |
| Q4 25 | -0.8% | 6.7% | ||
| Q3 25 | -0.7% | 6.2% | ||
| Q2 25 | 7.7% | 6.5% | ||
| Q1 25 | 6.2% | 9.9% | ||
| Q4 24 | 0.1% | 8.5% | ||
| Q3 24 | 5.6% | 6.8% | ||
| Q2 24 | 8.6% | 3.8% | ||
| Q1 24 | -5.2% | 8.0% |
| Q4 25 | $-0.11 | $1.99 | ||
| Q3 25 | $-0.10 | — | ||
| Q2 25 | $1.15 | — | ||
| Q1 25 | $0.86 | — | ||
| Q4 24 | $0.02 | — | ||
| Q3 24 | $0.82 | — | ||
| Q2 24 | $1.43 | — | ||
| Q1 24 | $-0.65 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.8M | $18.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $815.2M | $213.6M |
| Total Assets | $1.7B | $628.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.8M | $18.2M | ||
| Q3 25 | $23.7M | $22.5M | ||
| Q2 25 | $18.4M | $19.4M | ||
| Q1 25 | $8.3M | $25.6M | ||
| Q4 24 | $19.6M | $26.7M | ||
| Q3 24 | $17.3M | $24.5M | ||
| Q2 24 | $12.1M | $24.6M | ||
| Q1 24 | $20.6M | $37.1M |
| Q4 25 | $815.2M | $213.6M | ||
| Q3 25 | $818.2M | $201.7M | ||
| Q2 25 | $823.7M | $197.0M | ||
| Q1 25 | $794.4M | $227.3M | ||
| Q4 24 | $774.6M | $212.1M | ||
| Q3 24 | $766.4M | $204.5M | ||
| Q2 24 | $746.6M | $191.7M | ||
| Q1 24 | $713.2M | $211.8M |
| Q4 25 | $1.7B | $628.9M | ||
| Q3 25 | $1.7B | $629.0M | ||
| Q2 25 | $1.6B | $606.8M | ||
| Q1 25 | $1.6B | $590.4M | ||
| Q4 24 | $1.6B | $571.4M | ||
| Q3 24 | $1.5B | $582.3M | ||
| Q2 24 | $1.5B | $546.0M | ||
| Q1 24 | $1.5B | $552.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $63.7M | $22.4M |
| Free Cash FlowOCF − Capex | $36.1M | — |
| FCF MarginFCF / Revenue | 10.0% | — |
| Capex IntensityCapex / Revenue | 7.7% | — |
| Cash ConversionOCF / Net Profit | — | 1.70× |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.7M | $22.4M | ||
| Q3 25 | $26.6M | $36.5M | ||
| Q2 25 | $21.1M | $5.9M | ||
| Q1 25 | $11.4M | $-80.0M | ||
| Q4 24 | $64.2M | $79.4M | ||
| Q3 24 | $57.3M | $31.6M | ||
| Q2 24 | $50.2M | $1.8M | ||
| Q1 24 | $-36.2M | $-63.1M |
| Q4 25 | $36.1M | — | ||
| Q3 25 | $66.0K | $35.9M | ||
| Q2 25 | $-7.2M | $4.7M | ||
| Q1 25 | $-22.6M | $-81.0M | ||
| Q4 24 | $29.8M | $68.8M | ||
| Q3 24 | $26.8M | $28.6M | ||
| Q2 24 | $16.7M | $-509.0K | ||
| Q1 24 | $-71.6M | $-63.8M |
| Q4 25 | 10.0% | — | ||
| Q3 25 | 0.0% | 19.3% | ||
| Q2 25 | -1.7% | 2.5% | ||
| Q1 25 | -6.0% | -44.5% | ||
| Q4 24 | 9.1% | 39.0% | ||
| Q3 24 | 6.7% | 17.0% | ||
| Q2 24 | 3.7% | -0.3% | ||
| Q1 24 | -21.3% | -37.1% |
| Q4 25 | 7.7% | — | ||
| Q3 25 | 7.1% | 0.3% | ||
| Q2 25 | 6.9% | 0.6% | ||
| Q1 25 | 9.0% | 0.5% | ||
| Q4 24 | 10.4% | 6.0% | ||
| Q3 24 | 7.7% | 1.8% | ||
| Q2 24 | 7.4% | 1.4% | ||
| Q1 24 | 10.5% | 0.4% |
| Q4 25 | — | 1.70× | ||
| Q3 25 | — | 3.19× | ||
| Q2 25 | 0.67× | 0.48× | ||
| Q1 25 | 0.49× | -4.44× | ||
| Q4 24 | 182.29× | 5.30× | ||
| Q3 24 | 2.57× | 2.76× | ||
| Q2 24 | 1.29× | 0.28× | ||
| Q1 24 | — | -4.61× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
CRAI
Segment breakdown not available.
